SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?


To: Keiko who wrote (8481)3/10/1998 10:25:00 PM
From: DMore  Read Replies (3) | Respond to of 14328
 
Too bad ole Slick Willy wasn't neutered years ago.
A concern: sq. footage only increased 13,000. That is
supposed to be enough to handle all future needs. Seems
to me a much larger increase would have made sense.
I suppose we can expect currency adjustment, building
expenses, relocation expenses and savings from moving
Centocor business to all be added to .02/eps in the
future. Seems to me 1st qtr. should be much larger,
as well as all future qtrs. If not, there are some real
concerns about just how profitable these products really
are. '98 earnings much below .15 eps would a negative.
I don't see why with business ramping up, a doubling to
.12 should be a no brainer and my earlier post of 30%
qtr. over qtr. profit increase feasible.
D



To: Keiko who wrote (8481)3/12/1998 9:45:00 AM
From: Joel W. Hunt  Read Replies (1) | Respond to of 14328
 
KEIKO,

Hello from the beautiful....but wet Pacific Northwest and Boeing. One other commandment from Stock Market 101 is not to fall in love with any particular stock. I have to admit that I have somewhat of an infatuation with Trinity. But as in any relationship...if it doesn't move forward with time it becomes stale(stock term: "dead money"). I even got some people in Tokyo buying the stock. I must save face or commit seppaku (sp). Ha.

Joel

P.S. I think they got the wrong dog when they mentioned Buddy is going to get fixed.